Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Acelity appoints two new board members

Acelity appoints two new board members

3rd June 2015

Acelity has announced the appointment of two experienced professionals to its board of directors.

Kevin Buehler brings more than 30 years of experience in the healthcare and consumer industries to the role. He most recently served as the division head of Alcon Laboratories, at Novartis.

Meanwhile, Alexandre Decary will deliver strong business, financial and accounting experience. He currently serves as senior director for private equity at PSP Investments, where he is responsible for leading direct investments in various sectors.

His prior employment experience includes stints at data-driven marketing and loyalty analytics company Aimia and the investment banking group of RBC Capital Markets.

Joe Woody, president and chief executive officer of Acelity, said: "Kevin and Alexandre bring strong experiences in both global business and finance that will add unique and valuable perspectives to Acelity's board."

In 2014, the company achieved year-on-year growth of 7.7 percent, with the acquisition and integration of Systagenix highlighted as a key driver of momentum.ADNFCR-8000103-ID-801789913-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.